HOUSE DOCKET, NO. 3247 FILED ON: 1/14/2009
HOUSE . . . . . . . . . . . . . . No. 2351
The Commonwealth of Massachusetts
_______________
PRESENTED BY:
Viriato Manuel deMacedo
_______________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the passage of the accompanying bill:
An Act Regulating Appeals un
der the Group Insurance Commission.
_______________
PETITION OF:
|
Name:
|
District/Address:
|
|
Viriato Manuel deMacedo
|
1st Plymouth
|
|
James R. Miceli
|
19th Middlesex
|
|
Joyce A. Spiliotis
|
12th Essex
|
|
Christine E. Canavan
|
10th Plymouth
|
|
Thomas M. Stanley
|
9th Middlesex
|
|
Bruce E. Tarr
|
First Essex and Middlesex
|
The Commonwealth of Massachusetts
_______________
In the Year Two Thousand and Nine
_______________
An Act Regulating Appeals under the Group Insurance Commission.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Chapter 32A of the General Laws is hereby by amended, at the end thereof, the following new section:-
Section 17J. Any person who is dispensed a non-formulary or non-preferred brand name prescription drug, as determined under a pharmaceutical drug program established by the commission or through a pharmacy benefit manager contracted by the commission, may appeal that determination to the commission, and upon the submission of a statement by the person’s physician that, due to a medical necessity, only the non-formulary or non-preferred brand name prescription drug can be dispensed, the person shall pay for the drug at the same rate required for the formulary or preferred brand name prescription drugs under such pharmaceutical drug program.